MYCN mediates TFRC-dependent ferroptosis and reveals vulnerabilities in neuroblastoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MYCN mediates TFRC-dependent ferroptosis and reveals vulnerabilities in neuroblastoma
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 12, Issue 6, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-19
DOI
10.1038/s41419-021-03790-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MYCN-amplified neuroblastoma is addicted to iron and vulnerable to inhibition of the system Xc-/glutathione axis
- (2021) Konstantinos V. Floros et al. CANCER RESEARCH
- SnapShot: Ferroptosis
- (2020) Kamyar Hadian et al. CELL
- Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer
- (2020) Xiaoguang Liu et al. NATURE CELL BIOLOGY
- N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma
- (2020) Britta Tjaden et al. Scientific Reports
- Transferrin Receptor Is a Specific Ferroptosis Marker
- (2020) Huizhong Feng et al. Cell Reports
- MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma
- (2020) David King et al. Oncotarget
- N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway
- (2019) Yu Yin et al. Molecular Cancer
- Targeting Ferroptosis to Iron Out Cancer
- (2019) Behrouz Hassannia et al. CANCER CELL
- Metabolic reprogramming by MYCN confers dependence on the serine-glycine-one-carbon biosynthetic pathway
- (2019) Yingfeng Xia et al. CANCER RESEARCH
- The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma
- (2018) Heike Miess et al. ONCOGENE
- MYCN drives glutaminolysis in neuroblastoma and confers sensitivity to an ROS augmenting agent
- (2018) Tingting Wang et al. Cell Death & Disease
- The Expanding World of N-MYC–Driven Tumors
- (2018) David S. Rickman et al. Cancer Discovery
- Unsolved mysteries: How does lipid peroxidation cause ferroptosis?
- (2018) Huizhong Feng et al. PLOS BIOLOGY
- Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry
- (2018) Adam D. Durbin et al. NATURE GENETICS
- NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis
- (2017) Samantha W. Alvarez et al. NATURE
- MYCN induces neuroblastoma in primary neural crest cells
- (2017) R R Olsen et al. ONCOGENE
- The MYCN Protein in Health and Disease
- (2017) María Victoria Ruiz-Pérez et al. Genes
- Neuroblastoma
- (2016) Katherine K. Matthay et al. Nature Reviews Disease Primers
- SLC39A14 Is Required for the Development of Hepatocellular Iron Overload in Murine Models of Hereditary Hemochromatosis
- (2015) Supak Jenkitkasemwong et al. Cell Metabolism
- Glutaminolysis and Transferrin Regulate Ferroptosis
- (2015) Minghui Gao et al. MOLECULAR CELL
- Comparison of RNA-seq and microarray-based models for clinical endpoint prediction
- (2015) Wenqian Zhang et al. GENOME BIOLOGY
- ATF4 and N-Myc coordinate glutamine metabolism inMYCN-amplified neuroblastoma cells through ASCT2 activation
- (2014) Ping Ren et al. JOURNAL OF PATHOLOGY
- MYC and the Control of Apoptosis
- (2014) S. B. McMahon Cold Spring Harbor Perspectives in Medicine
- Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin
- (2013) VASYL F. CHEKHUN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma
- (2013) H Kocak et al. Cell Death & Disease
- Neuroblastoma and MYCN
- (2013) M. Huang et al. Cold Spring Harbor Perspectives in Medicine
- ATF4 Regulates MYC-Mediated Neuroblastoma Cell Death upon Glutamine Deprivation
- (2012) Guoliang Qing et al. CANCER CELL
- Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
- (2012) Sharon J Diskin et al. NATURE GENETICS
- Inhibition of transporter-mediated cystine uptake by sulfasalazine analogs
- (2011) Krupa Shukla et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthetic Lethal Screening Identifies Compounds Activating Iron-Dependent, Nonapoptotic Cell Death in Oncogenic-RAS-Harboring Cancer Cells
- (2008) Wan Seok Yang et al. CHEMISTRY & BIOLOGY
- High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma
- (2008) E. Fredlund et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now